This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Etsy (ETSY) Q2 Earnings Miss Estimates
by Zacks Equity Research
Etsy (ETSY) delivered earnings and revenue surprises of -53.70% and +3.80%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Markets Keep Nudging Higher Ahead of Trade Deals, CPI
by Mark Vickery
The S&P 500 is now at its highest level since February 20th.
PDD Holdings Inc. Sponsored ADR (PDD) Lags Q1 Earnings and Revenue Estimates
by Zacks Equity Research
PDD Holdings Inc. Sponsored ADR (PDD) delivered earnings and revenue surprises of -37.35% and 6.93%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Bear of the Day: PetMed Express (PETS)
by Ethan Feller
PetMed Express struggles with falling sales and declining earnings estimates
The Progressive and PetMed Express in the Box have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
The Progressive and PetMed Express in the Box have been highlighted as Zacks Bull and Bear of the Day
Here's Why PetMed (PETS) is a Strong Momentum Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why PetMed (PETS) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why PetMed (PETS) is a Strong Momentum Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
PetMed (PETS) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
PetMed (PETS) delivered earnings and revenue surprises of 283.33% and 9.77%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Beat the Market the Zacks Way: Bank of New York Mellon, PetMed, Ulta Beauty in Focus
by Santanu Roy
Our time-tested methodologies helped investors navigate the market well last week. Here are some of our key performance data from the past three months.
EBAY Q3 Earnings and Revenues Beat Estimates, Increase Y/Y
by Zacks Equity Research
EBAY's third-quarter 2024 results reflect a year-over-year increase in revenues and earnings, driven by Focus Categories and geo-specific investments.
4 Retail Stocks to Buy as Further Rate Cuts Loom
by Abhinab Dasgupta
Casey's, PetMed, Alibaba and Deckers Outdoor are four retail stocks that should do well in the coming months as the Fed finally initiates rate cuts.
Here's Why PetMed (PETS) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why PetMed (PETS) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Fiverr International (FVRR) Matches Q1 Earnings Estimates
by Zacks Equity Research
Fiverr (FVRR) delivered earnings and revenue surprises of 0% and 1.17%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
1stdibs.com (DIBS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
1stdibs (DIBS) delivered earnings and revenue surprises of 11.11% and 3.58%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
MercadoLibre (MELI) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
MercadoLibre (MELI) delivered earnings and revenue surprises of 2.11% and 9.86%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
PetMed (PETS) Reports Break-Even Earnings for Q2
by Zacks Equity Research
PetMed (PETS) delivered earnings and revenue surprises of -100% and 7.95%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
PetMeds (PETS) to Advance Pet Care With New Collaboration
by Zacks Equity Research
PetMeds (PETS) is positioning itself more firmly in the field of pet health and wellness as a result of its established reputation in the pet pharmaceutical industry.
PetMed (PETS) Reports Break-Even Earnings for Q1
by Zacks Equity Research
PetMed (PETS) delivered earnings and revenue surprises of -100% and 1.26%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for PetMed Express (PETS) Stock Options
by Zacks Equity Research
Investors need to pay close attention to PetMed Express (PETS) stock based on the movements in the options market lately.
Time for Pet ETF on Upbeat Earnings from Chewy? (Revised)
by Sanghamitra Saha
The recent impressive earnings report from Chewy, the online pet-products retailer, may ignite investor optimism in the segment and its pure-play ETF PETS.
PetMed (PETS) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
PetMed (PETS) delivered earnings and revenue surprises of -73.33% and 10.76%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Fiverr International (FVRR) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Fiverr (FVRR) delivered earnings and revenue surprises of 50% and 0.49%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
1stdibs.com (DIBS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
1stdibs (DIBS) delivered earnings and revenue surprises of 12.50% and 2.68%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?